An open-label multicenter study on the efficacy and safety of topical use of latanoprost for 156 weeks

Japanese Journal of Clinical Ophthalmology

Volumn 60, Issue 13, 2006, Pages 2047-2054

  Kitazawa, Yoshiaki ^a  

^a Akasaka Kitazawa Ophthalmic Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LATANOPROST;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; IRIS DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MICROSCOPY; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PIGMENTATION; SLIT LAMP; TREATMENT DURATION;

EID: 33846479235     PISSN: 03705579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Alm A, Schoenfelder J, McDermott J: A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma. Arch Ophthalmol 122: 957-965, 2004
2. Chiba T, Kashiwagi K, Kogure S et al: Iridial pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients. J Glaucoma 10: 406-410, 2001
3. Suzuki M, Mishima HK, Masuda K et al: Efficacy and safety of latanoprost eye drops for glaucoma treatment: a 1-year study in Japan. Jpn J Ophthalmol 44: 33-38, 2000
4. Japanese source
5. Dutkiewicz R, Albert DM, Levin LA: Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines. Exp Eye Res 70: 563-569, 2000
6. Kashiwagi K, Tsukamoto K, Suzuki M et al: Effects of isopropyl unoprostone and latanoprost on melanogenesis in mouse epidermal melanocytes. J Glaucoma 11: 57-64, 2002
7. Warwar RE, Bullock JD, Ballal D: Cystoid macular edema and anterior uveitis associated with latanoprost use: experience and incidence in a retrospective review of 94 patients. Ophthalmology 105: 263-268, 1998
8. Fechtner RD, Khouri AS, Zimmerman TJ et al: Anterior uveitis associated with latanoprost. Am J Ophthalmol 126: 37-41, 1998
9. Tomita G, Araie M, Kitazawa Y et al: A three-year prospective randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients. Eye 18: 984-989, 2004
10. Japanese source
11. Selen G, Stjernschantz J, Resul B: Prostaglandin-induced iridial pigmentation in primates. Surv Ophthalmol 41 (Suppl 2): S125-S128, 1997
12. Imesch PD, Wallow IH, Albert DM: The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation. Surv Ophthalmol 41 (Suppl 2): S117-S123, 1997
13. Grierson I, Lee WR, Albert DM: The fine structure of an iridectomy specimen from a patient with latanoprost-induced eye color change. Arch Ophthalmol 117: 394-396, 1999
14. Nakamura Y, Nakamura Y, Morine-Shinjo S et al: Assessment of chamber angle pigmentation during longterm latanoprost treatment for open-angle glaucoma. Acta Ophthalmol Scand 82: 158-160, 2004